New weight loss drug begins human testing
NCT ID NCT07399678
Summary
This early-stage study is testing a new drug called ALV-100 to see if it's safe for people to take and how their bodies process it. Researchers will enroll 180 overweight or obese adults, some with type 2 diabetes, to receive different doses or a placebo. The main goal is to check for side effects and see if the drug affects body weight and blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESE ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology of Miami
RECRUITINGMiami, Florida, 33172, United States
Conditions
Explore the condition pages connected to this study.